JPRN-UMIN000026383已完成1 期
Investigator initiated clinical trial of autologous synovial stem cells for meniscus lesions - Autologous synovial MSCs for meniscus lesions
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient who is unidentified 2) Patients who underwent menisectomy or meniscus repair in the affected knee 3) Patients whose clinical symptoms have been sufficiently improved by conservative treatments in the last 3 months 4) Patients with knee malalignment. 5) Patients with a history of trauma in the knee 6) Patients for whom MRI is not indicated because of claustrophobia and so on 7) Patients who have had any intraarticular injections (local anesthetic agent, corticosteroid agent, hyaluronic acid) or arthrocentesis in these 3 months. 8) Patients with active infection 9) Patients diagnosed or suspected as malignant tumor in these 5 years 10) Patients sensitive to antibiotics (penicillin, streptomycin or amphotericin B) 11) Patients sensitive to animal (bovine) origin materials 12) Patients with poor controlled diabetes 13) Patients with a pacemaker 14) Patients with poor general condition with following complication; -severe cardiovascular disease -severe liver disorder -severe kidney dysfunction -poorly controlled psychiatric disorder -other diseases which sudden deterioration or aggravation is foreseeable during the study period 15) Pregnant women, lactating women and patient who may be pregnant, or patient who desires pregnancy during clinical study 16) Patient who participated in other clinical trials, patient participating in other clinical studies and patient planning to participate in other clinical studies while participating in this clinical study within 12 weeks before the start of transplantation of cellular product 17) Patient for whom doctors decide as not appropriate to participate in the clinical study
研究者
相似试验
已完成
不适用
Investigator-initiated clinical trial: Autologous peripheral blood-derived CD34+ cells transplantation for bone and vascular regeneration using with MB-001 and IK-02 in patients with Fracture non-union.Fracture non-unionJPRN-UMIN000022814Foundation for Biomedical Research and Innovation at Kobe15
已完成
不适用
Investigator initiated clinical study on the efficacy and safety of autologous cultured chondrocyte processed product (IK-01) in patients with focal articular cartilage lesion in the kneeJPRN-UMIN000008171Ryosuke Kuroda, M.D., Ph.D10
已完成
不适用
Investigator initiated clinical trial to validate usefulness of specific system for endoscopic ultrasound guided hepaticogastrostomy (HG01) in malignant biliary obstructioBiliary obstruction due to unresectable malignant tumorsMalignant biliary obstruction, Endoscopic ultrasound, Biliary drainage, HepatocogastrostomyD001660JPRN-jRCT2052210020Kitano Masayuki40
招募中
不适用
131I-Rituximab consolidation in advanced diffuse large B-cell lymphomaNeoplasmsKCT0000526Korea Institute of Radiological & Medical Sciences56
已完成
1 期
Phase I investigator initiated clinical trial using a novel WT1 peptide vaccine for patients with metastatic pancreatic cancerpancreatic cancerJPRN-UMIN000029428Wakayama Medical University6